» Authors » Mark Wiley

Mark Wiley

Explore the profile of Mark Wiley including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 22
Citations 96
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Fioretti F, Hibbert B, Eckman P, Simard T, Labinaz M, Nazer B, et al.
JACC Heart Fail . 2025 Feb; PMID: 40019407
Background: The ALT-FLOW trial EFS (Early Feasibility Study) evaluated safety, hemodynamics and outcomes for the APTURE system in patients with HF and mildly reduced or preserved ejection fraction. Objectives: In...
2.
Vasudeva R, Mehta H, Chan W, Jiwani S, Yarlagadda S, Acharya P, et al.
Ann Transl Med . 2025 Jan; 12(6):111. PMID: 39817250
Background: Patients with end-stage kidney disease (ESKD) are at high risk for coronary artery disease. We investigate the trends and outcomes of percutaneous coronary intervention (PCI) for stable ischemic heart...
3.
Mehta H, Gheith Z, Amin S, Acharya P, Daon E, Downey P, et al.
Kans J Med . 2024 Jun; 17:45-50. PMID: 38859990
Introduction: Traumatic cardiac injury (TCI) poses a significant risk of morbidity and mortality, yet there is a lack of population-based outcomes data for these patients. Methods: The authors examined national...
4.
Vasudeva R, Mehta H, Chan W, Majmundar M, Yarlagadda S, Downey P, et al.
Am J Cardiol . 2024 Apr; 210:37-43. PMID: 38682717
Patients with end-stage kidney disease (ESKD) on dialysis have an increased burden of coronary artery disease (CAD). This study assessed the trend and outcomes for coronary artery bypass surgery (CABG)...
5.
Urey M, Hibbert B, Jorde U, Eckman P, Simard T, Labinaz M, et al.
Eur J Heart Fail . 2024 Apr; 26(4):1065-1077. PMID: 38606485
Aims: Patients with heart failure and mildly reduced or preserved ejection fraction have limited therapeutic options. The ALT-FLOW Early Feasibility Study evaluated safety, haemodynamics and outcomes for the APTURE transcatheter...
6.
Mehta H, Chan W, Aday A, Jones W, Parmar G, Hance K, et al.
J Vasc Surg . 2024 Jan; 79(5):1170-1178.e10. PMID: 38244643
Objective: Patients with peripheral artery disease (PAD) and end-stage kidney disease are a high-risk population, and concomitant atherosclerosis in coronary arteries (CAD) or cerebral arteries (CVD) is common. The aim...
7.
Jiwani S, Chan W, Majmundar M, Patel K, Mehta H, Sharma A, et al.
Vasc Med . 2023 Nov; 29(2):135-142. PMID: 37936422
Background: Atherosclerotic cardiovascular disease is highly prevalent in patients with end-stage kidney disease (ESKD). Kidney transplant (KT) improves patient survival and cardiovascular outcomes. The impact of preexisting coronary artery disease...
8.
Vindhyal M, Vasudeva R, Chan W, Tadros P, Wiley M, Gunasekaran P, et al.
Ann Transl Med . 2023 Apr; 11(6):277. PMID: 37082679
No abstract available.
9.
Hibbert B, Zahr F, Simard T, Labinaz M, Nazer B, Sorajja P, et al.
JACC Cardiovasc Interv . 2023 Mar; 16(11):1369-1380. PMID: 36989271
Background: Heart failure (HF) is associated with both mortality and a significant decline in health status. Interatrial shunting is increasingly being investigated as a novel therapeutic option. Objectives: The ALT...
10.
Alahmad M, Acharya P, Gibson C, Wiley M, Hockstad E, Gupta K
Am J Cardiol . 2022 Nov; 186:30-35. PMID: 36343443
Cachexia is often seen in patients with heart failure (HF). This study aimed to examine the association between cachexia and clinical outcomes in patients hospitalized for HF. We extracted all...